Kraig Biocraft Laboratories (KBLB) Current Leases (2019 - 2022)
Kraig Biocraft Laboratories (KBLB) has disclosed Current Leases for 3 consecutive years, with $49479.0 as the latest value for Q3 2022.
- Quarterly Current Leases rose 47.73% to $49479.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $49479.0 through Sep 2022, up 47.73% year-over-year, with the annual reading at $44577.0 for FY2021, N/A changed from the prior year.
- Current Leases hit $49479.0 in Q3 2022 for Kraig Biocraft Laboratories, up from $47811.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $115995.0 in Q2 2021 to a low of $33492.0 in Q3 2021.
- Historically, Current Leases has averaged $69344.5 across 3 years, with a median of $48645.0 in 2022.
- Biggest YoY gain for Current Leases was 47.73% in 2022; the steepest drop was 58.78% in 2022.
- Year by year, Current Leases stood at $107661.0 in 2019, then crashed by 58.6% to $44577.0 in 2021, then grew by 11.0% to $49479.0 in 2022.
- Business Quant data shows Current Leases for KBLB at $49479.0 in Q3 2022, $47811.0 in Q2 2022, and $46178.0 in Q1 2022.